Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Martin Vordermeier

Showing results (41-50 of 113) with videos related to

Pageof 12
Sort By:
Heliyon|January 2, 2023
The safety of BCG vaccination in cattle: results from good laboratory practice safety studies in calves and lactating cowsGareth A Williams, Emer Scott-Baird, Alejandro Núñez, et al.
Infection and Immunity|October 27, 2004
Recognition of mycobacterial antigens delivered by genetically detoxified Bordetella pertussis adenylate cyclase by T cells from cattle with bovine tuberculosisH Martin Vordermeier, Marcela Simsova, Katalin A Wilkinson, et al.
Infection and Immunity|April 23, 2004
Association of tuberculin-boosted antibody responses with pathology and cell-mediated immunity in cattle vaccinated with Mycobacterium bovis BCG and infected with M. bovisKonstantin Lyashchenko, Adam O Whelan, Rena Greenwald, et al.
Infection and Immunity|June 4, 2008
Screening of highly expressed mycobacterial genes identifies Rv3615c as a useful differential diagnostic antigen for the Mycobacterium tuberculosis complexBen Sidders, Chris Pirson, Philip J Hogarth, et al.
Vaccine|April 16, 2018
Ag85A-specific CD4<sup>+</sup> T cell lines derived after boosting BCG-vaccinated cattle with Ad5-85A possess both mycobacterial growth inhibition and anti-inflammatory propertiesHannah J Metcalfe, Lucia Biffar, Sabine Steinbach, et al.
Tuberculosis (Edinburgh, Scotland)|February 3, 2005
Cattle as a model for development of vaccines against human tuberculosisBryce M Buddle, Margot A Skinner, D Neil Wedlock, et al.
Tuberculosis (Edinburgh, Scotland)|August 3, 2011
Low oral BCG doses fail to protect cattle against an experimental challenge with Mycobacterium bovisBryce M Buddle, Frank E Aldwell, Geoffrey W de Lisle, et al.
Veterinary Immunology and Immunopathology|December 18, 2019
Biomarkers of cell-mediated immunity to bovine tuberculosisMitchell V Palmer, Tyler C Thacker, Meaghan M Rabideau, et al.
Current Gene Therapy|October 28, 2005
Recent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccinesZhou Xing, Michael Santosuosso, Sarah McCormick, et al.
Clinical and Vaccine Immunology : CVI|March 14, 2008
Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG with a Mycobacterial protein vaccine-adjuvant combination but not after coadministration of adjuvant aloneD Neil Wedlock, Michel Denis, Gavin F Painter, et al.
Pageof 12

Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
Heliyon|January 2, 2023
The safety of BCG vaccination in cattle: results from good laboratory practice safety studies in calves and lactating cowsGareth A Williams, Emer Scott-Baird, Alejandro Núñez, et al.
Infection and Immunity|October 27, 2004
Recognition of mycobacterial antigens delivered by genetically detoxified Bordetella pertussis adenylate cyclase by T cells from cattle with bovine tuberculosisH Martin Vordermeier, Marcela Simsova, Katalin A Wilkinson, et al.
Infection and Immunity|April 23, 2004
Association of tuberculin-boosted antibody responses with pathology and cell-mediated immunity in cattle vaccinated with Mycobacterium bovis BCG and infected with M. bovisKonstantin Lyashchenko, Adam O Whelan, Rena Greenwald, et al.
Infection and Immunity|June 4, 2008
Screening of highly expressed mycobacterial genes identifies Rv3615c as a useful differential diagnostic antigen for the Mycobacterium tuberculosis complexBen Sidders, Chris Pirson, Philip J Hogarth, et al.
Vaccine|April 16, 2018
Ag85A-specific CD4<sup>+</sup> T cell lines derived after boosting BCG-vaccinated cattle with Ad5-85A possess both mycobacterial growth inhibition and anti-inflammatory propertiesHannah J Metcalfe, Lucia Biffar, Sabine Steinbach, et al.
Tuberculosis (Edinburgh, Scotland)|February 3, 2005
Cattle as a model for development of vaccines against human tuberculosisBryce M Buddle, Margot A Skinner, D Neil Wedlock, et al.
Tuberculosis (Edinburgh, Scotland)|August 3, 2011
Low oral BCG doses fail to protect cattle against an experimental challenge with Mycobacterium bovisBryce M Buddle, Frank E Aldwell, Geoffrey W de Lisle, et al.
Veterinary Immunology and Immunopathology|December 18, 2019
Biomarkers of cell-mediated immunity to bovine tuberculosisMitchell V Palmer, Tyler C Thacker, Meaghan M Rabideau, et al.
Current Gene Therapy|October 28, 2005
Recent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccinesZhou Xing, Michael Santosuosso, Sarah McCormick, et al.
Clinical and Vaccine Immunology : CVI|March 14, 2008
Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG with a Mycobacterial protein vaccine-adjuvant combination but not after coadministration of adjuvant aloneD Neil Wedlock, Michel Denis, Gavin F Painter, et al.
Pageof 12